SAMAHA ELI sold 3.5% of their position (336.70K shares) of THERAVANCE BIOPHARMA, INC. on the open market
Open‑market sale worth $5.79M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 7/1/2026ACC: 0001877589-26-000001
-336.70K
Net shares
Net seller
$5.79M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
336.70K disposed
Non-Derivative Transactions3
COM
Indirect
Shares
−273.87K
Price / share
$17.23
Trade value
$4.72M
% of position
2.9%
6/29/2026
9.51M→9.24M
COM
Indirect
Shares
−25.03K
Price / share
$17.13
Trade value
$428.79K
% of position
0.3%
6/30/2026
9.24M→9.21M
COM
Indirect
Shares
−37.80K
Price / share
$17.00
Trade value
$642.63K
% of position
0.4%
7/1/2026
9.21M→9.17M
Total
Net shares
−336.70K
Net value
-$5.79M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COM Indirect | 6/29/2026 | S · Sale | −273.87K | $17.23 | $4.72M | 2.9% | 9.51M | 9.24M |
| COM Indirect | 6/30/2026 | S · Sale | −25.03K | $17.13 | $428.79K | 0.3% | 9.24M | 9.21M |
| COM Indirect | 7/1/2026 | S · Sale | −37.80K | $17.00 | $642.63K | 0.4% | 9.21M | 9.17M |
| Total | −336.70K | -$5.79M | ||||||
Derivative Transactions0
No derivative transactions reported